jmelkington

10 ms·

31.
New Medicines #6(medium.com)
1 points by jmelkington 6y ago|0 comments
32.
Life Sciences Observations #15(medium.com)
1 points by jmelkington 6y ago|0 comments
33.
Case Study on Distributed Bio(axial.substack.com)
1 points by jmelkington 6y ago|0 comments
34.
New frontiers in life sciences #1(axial.substack.com)
1 points by jmelkington 6y ago|0 comments
35.
Commoditizing your complement in life sciences(axial.substack.com)
1 points by jmelkington 6y ago|0 comments
36.
New Medicines #6(medium.com)
2 points by jmelkington 6y ago|0 comments
37.
Life Sciences Observations #15(medium.com)
2 points by jmelkington 6y ago|0 comments
38.
Case Study on Ginkgo Bioworks(axial.substack.com)
1 points by jmelkington 6y ago|0 comments
39.
Case Study on Color Genomics(axial.substack.com)
1 points by jmelkington 6y ago|0 comments
40.
by jmelkington 6y ago
Thanks - to be determined on DiCE's lead program; but the idea is to replace an antibody with a small molecule to gain delivery advantages.
41.
Undruggable Genome(medium.com)
2 points by jmelkington 6y ago|0 comments
42.
Case Study on PatientPing(axial.substack.com)
1 points by jmelkington 6y ago|0 comments
43.
Life Sciences Financings and Commentary #12(medium.com)
1 points by jmelkington 6y ago|0 comments
44.
DiCE Molecules(axial.substack.com)
16 points by jmelkington 6y ago|2 comments
45.
Founder-driven life sciences companies(axial.substack.com)
1 points by jmelkington 6y ago|0 comments
46.
The Superinvestors of Life Sciences(axial.substack.com)
1 points by jmelkington 6y ago|0 comments
47.
Case Study on Ginkgo Bioworks(axial.substack.com)
1 points by jmelkington 6y ago|0 comments
48.
Life Sciences Observations #14(medium.com)
1 points by jmelkington 6y ago|0 comments
49.
Vividion Therapeutics – targeted protein degradation(medium.com)
1 points by jmelkington 6y ago|0 comments
50.
Novome – genetically engineered microbes for kidney stones(medium.com)
1 points by jmelkington 6y ago|0 comments
51.
Axial – Agency for Great Inventors(twitter.com)
1 points by jmelkington 6y ago|0 comments
52.
New Medicines #5(medium.com)
2 points by jmelkington 6y ago|0 comments
53.
Life Sciences Observations #14(medium.com)
1 points by jmelkington 6y ago|0 comments
54.
Life Sciences Financings and Commentary #11(medium.com)
2 points by jmelkington 6y ago|0 comments
55.
Business Model Matrix(axial.substack.com)
2 points by jmelkington 6y ago|0 comments
56.
Case Study on Color Genomics(axial.substack.com)
2 points by jmelkington 6y ago|0 comments
57.
Life Sciences Observations #13(medium.com)
2 points by jmelkington 6y ago|0 comments
58.
Life Sciences Financings and Commentary #10(medium.com)
1 points by jmelkington 6y ago|0 comments
59.
Substitutes and Complements in Life Sciences(axial.substack.com)
1 points by jmelkington 6y ago|0 comments
60.
New Medicines #4(medium.com)
1 points by jmelkington 6y ago|0 comments

More ›